Premium
Therapeutic concepts of brachytherapy/megavoltage in sequence for pharyngeal wall cancers results of integrated dose therapy
Author(s) -
Son Yung H.,
Kacinski Barry M.
Publication year - 1987
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19870401)59:7<1268::aid-cncr2820590707>3.0.co;2-9
Subject(s) - medicine , brachytherapy , radiation therapy , dose rate , cancer , radiology , hypopharyngeal cancer , nuclear medicine , medical physics
This is a follow‐up report on lateral, posterior oro‐, hypopharyngeal wall cancer treatment based on a new therapeutic concept. Ir‐192 or I‐125 brachytherapy and craniocervical megavoltage irradiation are effective with improved local control and NED (no evidence of disease) survival rates. Local failure rate is 14% and actuarial survival (NED) is 82% at 5 years in 14 patients treated thus far.